Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Tumor Progression

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...

Drug Discovery: Overview

Drug Discovery: Overview

Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...

The Central Dogma

The Central Dogma

The central dogma explains the flow of genetic information from DNA nucleotides to the amino acid sequence of proteins.
RNA is the Missing Link Between DNA and Proteins
In the early 1900s, scientists discovered that DNA stores all the information needed for cellular functions and that proteins perform most of these functions. However, the mechanisms of converting genetic information into functional proteins remained unknown for many years. Initially, it was believed that a single gene is...

Microorganisms in Medicine and Therapeutics

Microorganisms in Medicine and Therapeutics

Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...

Preclinical Development: Overview

Preclinical Development: Overview

Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

CROI 2026: Basic Science Highlights From the 2026 Conference on Retroviruses and Opportunistic Infections.

Topics in antiviral medicine·2026

Same author

Proof-of-concept of host attribution of antimicrobial resistance genes using wastewater Hi-C metagenome sequencing.

Journal of water and health·2026

Same author

Wastewater SARS-CoV-2 and COVID-19 Hospital Admission and Mortality - A Controlled Experimental Study.

medRxiv : the preprint server for health sciences·2026

Same author

CROI 2025: Summary of Basic Science Research in HIV.

Topics in antiviral medicine·2025

Same author

Long term assessment of SARS-CoV-2 in wastewater and the transition to evaluate additional viral targets.

The Science of the total environment·2025

Same author

An observational cohort study evaluating PrEP reach, engagement and persistence through a community-based mobile clinic in Miami-Dade County, Florida.

Journal of the International AIDS Society·2024

Same journal

Occupational postexposure prophylaxis for HIV: The PEPline perspective.

Topics in HIV medicine : a publication of the International AIDS Society, USA·2011

Same journal

Recalcitrant giant molluscum contagiosum in a patient with advanced HIV disease - eradication of disease with paclitaxel.

Topics in HIV medicine : a publication of the International AIDS Society, USA·2011

Same journal

Evaluating and managing cardiovascular disease risk factors in HIV-infected patients.

Topics in HIV medicine : a publication of the International AIDS Society, USA·2011

Same journal

Update of the drug resistance mutations in HIV-1: December 2010.

Topics in HIV medicine : a publication of the International AIDS Society, USA·2011

Same journal

Current issues in the diagnosis and management of tuberculosis and HIV coinfection in the United States.

Topics in HIV medicine : a publication of the International AIDS Society, USA·2010

Same journal

Sexually transmitted infections and HIV: epidemiology and interventions.

Topics in HIV medicine : a publication of the International AIDS Society, USA·2010

See all related articles

Search research articles

Related Experiment Video

Updated: Jun 12, 2026

In Vitro Intraluminal Gel Infusion: An Advanced Approach for Microscopic Analysis of Human Resistance Arteries

In Vitro Intraluminal Gel Infusion: An Advanced Approach for Microscopic Analysis of Human Resistance Arteries

Published on: August 19, 2025

Advances in basic science.

Mario Stevenson¹

¹Department of Molecular Genetics and Microbiology, University of Massachusetts Medical School, Worcester, MA, USA.

Topics in HIV Medicine : a Publication of the International AIDS Society, USA

|June 3, 2010

Summary

This summary is machine-generated.

Advances in basic science at the Conference on Retroviruses and Opportunistic Infections highlight cellular defenses against lentiviruses. Understanding these viral-host interactions and primate lentiviral pathogenicity offers new strategies against HIV-1.

More Related Videos

Two-Photon Calcium Imaging of Forebrain Activity in Behaving Adult Zebrafish

Two-Photon Calcium Imaging of Forebrain Activity in Behaving Adult Zebrafish

Published on: July 28, 2023

Related Experiment Videos

Last Updated: Jun 12, 2026

In Vitro Intraluminal Gel Infusion: An Advanced Approach for Microscopic Analysis of Human Resistance Arteries

In Vitro Intraluminal Gel Infusion: An Advanced Approach for Microscopic Analysis of Human Resistance Arteries

Published on: August 19, 2025

Two-Photon Calcium Imaging of Forebrain Activity in Behaving Adult Zebrafish

Two-Photon Calcium Imaging of Forebrain Activity in Behaving Adult Zebrafish

Published on: July 28, 2023

Area of Science:

Virology
Immunology
Genomics

Background:

Basic science research is crucial for understanding viral-host interactions.
Cellular factors and defenses significantly impact viral replication.
Primate lentiviral pathogenicity mechanisms are a key area of study.

Purpose of the Study:

To summarize key findings on cellular factors regulating virus-host interplay.
To explore advances in understanding cellular defenses like tetherin (BST-2).
To examine the evolution and pathogenicity of primate lentiviruses.

Main Methods:

Review of presentations from the 17th Conference on Retroviruses and Opportunistic Infections.
Analysis of research on cellular factors and viral antagonism.
Examination of lentiviral and primate genome evolution.

Main Results:

Focus on cellular defenses, including tetherin (BST-2), that antagonize viral replication.
Significant interest in basic mechanisms of primate lentiviral pathogenicity.
Lentiviral accessory proteins are involved in overcoming natural antiviral restrictions.

Conclusions:

Viral-host genome evolution reveals a continuous conflict.
Lentiviruses have evolved complex strategies to replicate in primate hosts.
Harnessing natural cellular restrictions presents a strong rationale for therapeutic strategies against lentiviruses like HIV-1.